{"id":"https://openalex.org/W2129679336","doi":"https://doi.org/10.1158/1535-7163.mct-11-0167","title":"The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells","display_name":"The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells","alternate_titles":[],"publication_year":2011,"publication_date":"2011-06-01","ids":{"openalex":"https://openalex.org/W2129679336","doi":"https://doi.org/10.1158/1535-7163.mct-11-0167","mag":"2129679336","pmid":"https://pubmed.ncbi.nlm.nih.gov/21490307","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4727401"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-11-0167","doi":"https://doi.org/10.1158/1535-7163.mct-11-0167","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0167","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/6/1018/2321253/1018.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2129679336"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://aacrjournals.org/mct/article-pdf/10/6/1018/2321253/1018.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060790276","display_name":"Wei Fu","orcid":"https://orcid.org/0000-0003-0506-5594","observed_orcids":["https://orcid.org/0000-0003-0506-5594"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wei Fu","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111931267","display_name":"Le Ma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Le Ma","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043580869","display_name":"Baoky Chu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Baoky Chu","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100422557","display_name":"Xue Wang","orcid":"https://orcid.org/0000-0002-0423-1952","observed_orcids":["https://orcid.org/0000-0002-0423-1952"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xue Wang","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022728544","display_name":"Marilyn M. Bui","orcid":"https://orcid.org/0000-0003-4963-2255","observed_orcids":["https://orcid.org/0000-0003-4963-2255"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marilyn M. Bui","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001167914","display_name":"Jennifer Y. Gemmer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jennifer Gemmer","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043205942","display_name":"Soner Altiok","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Soner Altiok","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113706405","display_name":"W. Jackson Pledger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W. Jackson Pledger","raw_affiliation_strings":["Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations: Departments of Molecular Oncology1, Experimental Therapeutics2, and Sarcoma3, Gonzmart Research Laboratory, Sarcoma Research Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I3019308854"],"apc_list":null,"apc_paid":null,"fwci":4.5283,"has_fulltext":true,"cited_by_count":86,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.95487966,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"10","issue":"6","first_page":"1018","last_page":"1027"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.8452000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10583","display_name":"Cancer-related Molecular Pathways","score":0.11410000175237656,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.016100000590085983,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/osteosarcoma","display_name":"osteosarcoma","score":0.8659999966621399},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.9039999842643738},{"id":"https://openalex.org/keywords/cdk1","display_name":"CDK1","score":0.8679999709129333},{"id":"https://openalex.org/keywords/cdk2","display_name":"CDK2","score":1.0},{"id":"https://openalex.org/keywords/mitochondrial-apoptosis","display_name":"mitochondrial apoptosis","score":0.8069999814033508},{"id":"https://openalex.org/keywords/caspase-9","display_name":"caspase-9","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cytochrome-c","display_name":"cytochrome c","score":0.8529999852180481},{"id":"https://openalex.org/keywords/bax","display_name":"Bax","score":0.871999979019165},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.9769999980926514},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9649999737739563},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6790000200271606},{"id":"https://openalex.org/keywords/doxorubicin-resistance","display_name":"doxorubicin resistance","score":0.9179999828338623},{"id":"https://openalex.org/keywords/dasatinib-resistance","display_name":"dasatinib resistance","score":0.9860000014305115},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.671999990940094},{"id":"https://openalex.org/keywords/p53-independent-apoptosis","display_name":"p53-independent apoptosis","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C2777760704","wikidata":"https://www.wikidata.org/wiki/Q549534","display_name":"Osteosarcoma","level":2,"score":0.9111773371696472},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.7526029348373413},{"id":"https://openalex.org/C124320809","wikidata":"https://www.wikidata.org/wiki/Q46292","display_name":"Cyclin-dependent kinase","level":4,"score":0.6840820908546448},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6345981359481812},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4958723485469818},{"id":"https://openalex.org/C120504264","wikidata":"https://www.wikidata.org/wiki/Q1147372","display_name":"Cyclin-dependent kinase 1","level":4,"score":0.4860978126525879},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.43700259923934937},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.43570971488952637},{"id":"https://openalex.org/C82495950","wikidata":"https://www.wikidata.org/wiki/Q14911732","display_name":"Cyclin-dependent kinase 2","level":4,"score":0.4105852544307709},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37372270226478577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3356223404407501},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30657958984375},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.24636688828468323},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.19256740808486938},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15405631065368652},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10102027654647827}],"mesh":[{"descriptor_ui":"D000072224","descriptor_name":"Bcl-2-Like Protein 11","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D001859","descriptor_name":"Bone Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003497","descriptor_name":"Cyclic N-Oxides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007212","descriptor_name":"Indolizines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008928","descriptor_name":"Mitochondria","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011726","descriptor_name":"Pyridinium Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D012516","descriptor_name":"Osteosarcoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016203","descriptor_name":"CDC2 Protein Kinase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016203","descriptor_name":"CDC2 Protein Kinase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019253","descriptor_name":"Proto-Oncogene Proteins c-bcl-2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045304","descriptor_name":"Cytochromes c","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051017","descriptor_name":"Apoptosis Regulatory Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051028","descriptor_name":"bcl-2-Associated X Protein","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051357","descriptor_name":"Cyclin-Dependent Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051357","descriptor_name":"Cyclin-Dependent Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053453","descriptor_name":"Caspase 9","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.mct-11-0167","doi":"https://doi.org/10.1158/1535-7163.mct-11-0167","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0167","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/6/1018/2321253/1018.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:21490307","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21490307","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4727401","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4727401/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.mct-11-0167","doi":"https://doi.org/10.1158/1535-7163.mct-11-0167","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-11-0167","pdf_url":"https://aacrjournals.org/mct/article-pdf/10/6/1018/2321253/1018.pdf","source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000876523","display_name":"Moffitt Cancer Center Support Grant","funder_award_id":"P30CA076292","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2129679336.pdf","grobid_xml":"https://content.openalex.org/works/W2129679336.grobid-xml"},"referenced_works_count":55,"referenced_works":["https://openalex.org/W31572314","https://openalex.org/W186831022","https://openalex.org/W1940692702","https://openalex.org/W1973586213","https://openalex.org/W1981999643","https://openalex.org/W1983171715","https://openalex.org/W1991054314","https://openalex.org/W1999844887","https://openalex.org/W2003946870","https://openalex.org/W2005173284","https://openalex.org/W2011017763","https://openalex.org/W2011994306","https://openalex.org/W2017413811","https://openalex.org/W2022387751","https://openalex.org/W2031203111","https://openalex.org/W2033280463","https://openalex.org/W2034681029","https://openalex.org/W2037085321","https://openalex.org/W2040440596","https://openalex.org/W2044312503","https://openalex.org/W2044332600","https://openalex.org/W2044365359","https://openalex.org/W2047884499","https://openalex.org/W2055931677","https://openalex.org/W2056114994","https://openalex.org/W2063644591","https://openalex.org/W2079237350","https://openalex.org/W2080747093","https://openalex.org/W2083433702","https://openalex.org/W2090206737","https://openalex.org/W2092042999","https://openalex.org/W2098203835","https://openalex.org/W2104373322","https://openalex.org/W2106856578","https://openalex.org/W2126552753","https://openalex.org/W2128956884","https://openalex.org/W2132441117","https://openalex.org/W2132789732","https://openalex.org/W2133459528","https://openalex.org/W2135129680","https://openalex.org/W2135546245","https://openalex.org/W2140448223","https://openalex.org/W2140642045","https://openalex.org/W2140955159","https://openalex.org/W2143805081","https://openalex.org/W2144002245","https://openalex.org/W2147347134","https://openalex.org/W2149044230","https://openalex.org/W2150048195","https://openalex.org/W2152398347","https://openalex.org/W2157023753","https://openalex.org/W2162517036","https://openalex.org/W2163931326","https://openalex.org/W4239718055","https://openalex.org/W6670572448"],"related_works":["https://openalex.org/W2028118735","https://openalex.org/W2050941854","https://openalex.org/W1998935881","https://openalex.org/W2415183483","https://openalex.org/W2090514619","https://openalex.org/W2790157952","https://openalex.org/W2740555626","https://openalex.org/W4309402749","https://openalex.org/W1439244150","https://openalex.org/W3018682125"],"abstract_inverted_index":{"Although":[0],"rare,":[1],"osteosarcoma":[2,39,68,156],"is":[3],"an":[4],"aggressive":[5],"cancer":[6],"that":[7,25,150,164],"often":[8],"metastasizes":[9],"to":[10,45,75],"the":[11,14,26,35,94,112,124,153,177],"lungs.":[12],"Toward":[13],"goal":[15],"of":[16,37,83,97,106,111,123,136,144,155,171,179,185],"developing":[17],"new":[18],"treatment":[19,170],"options":[20],"for":[21,169],"osteosarcoma,":[22],"we":[23],"show":[24],"cyclin-dependent":[27],"kinase":[28],"(CDK)":[29],"inhibitor":[30],"SCH":[31,92,151,165,174],"727965":[32],"(SCH)":[33],"induces":[34],"apoptosis":[36,98,154,178],"several":[38],"cell":[40],"lines":[41,50],"including":[42],"those":[43],"resistant":[44],"doxorubicin":[46],"and":[47,62,89,104,116,128,138,161,163],"dasatinib.":[48],"Cell":[49],"prepared":[51],"in":[52,70,119],"our":[53],"laboratory":[54],"from":[55,65],"patients":[56],"who":[57],"had":[58],"received":[59],"adjuvant":[60],"chemotherapy":[61],"explants":[63],"derived":[64],"a":[66],"human":[67],"xenograft":[69],"mice":[71],"were":[72],"also":[73,175],"responsive":[74],"SCH.":[76],"Apoptosis":[77],"occurred":[78],"at":[79],"low":[80],"nanomolar":[81],"concentrations":[82],"SCH,":[84],"as":[85,99],"did":[86],"CDK":[87,146],"inhibition,":[88],"was":[90],"p53-independent.":[91],"activated":[93],"mitochondrial":[95],"pathway":[96],"evidenced":[100],"by":[101,158],"caspase-9":[102],"cleavage":[103],"accumulation":[105],"cytoplasmic":[107],"cytochrome":[108],"c.":[109],"Amounts":[110],"apoptotic":[113],"proteins":[114,126],"Bax":[115],"Bim":[117],"increased":[118],"mitochondria,":[120],"whereas":[121],"amounts":[122],"antiapoptotic":[125],"Mcl-1":[127],"Bcl-x(L)":[129],"declined.":[130],"Osteosarcoma":[131],"cells":[132,157],"apoptosed":[133],"when":[134,142],"codepleted":[135],"CDK1":[137,160],"CDK2":[139,162],"but":[140,183],"not":[141,184],"depleted":[143],"other":[145,180],"combinations.":[147],"We":[148],"suggest":[149],"triggers":[152],"inactivating":[159],"may":[166],"be":[167],"useful":[168],"drug-resistant":[172],"osteosarcomas.":[173],"induced":[176],"sarcoma":[181],"types":[182],"normal":[186],"quiescent":[187],"osteoblasts":[188],"or":[189],"fibroblasts.":[190]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2129679336","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
